Supplementary Figure S1 from Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children’s Oncology Group

Florette K. Hazard; Angus M.S. Toland; Serena Y. Tan; Bill Chiu; Naohiko Ikegaki; Arlene H. Naranjo; Susan Lerner Cohn; Wendy B. London; Julie M. Gastier‐Foster; Nilsa C. Ramirez; Shalini C. Reshmi; Elizabeth Wagner; Jed G. Nuchtern; Shahab Asgharzadeh; Araz Marachelian; John M. Maris; Rochelle Bagatell; Julie R. Park; Meredith S. Irwin; Michael D. Hogarty; Hiroyuki Shimada

doi:10.1158/1078-0432.31006693

Supplementary Figure S1 from Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children’s Oncology Group

2026 Open access

Read full text

Authors: Florette K. Hazard, Angus M.S. Toland, Serena Y. Tan, Bill Chiu, Naohiko Ikegaki, Arlene H. Naranjo, Susan Lerner Cohn, Wendy B. London, Julie M. Gastier‐Foster, Nilsa C. Ramirez, Shalini C. Reshmi, Elizabeth Wagner

+9 more

Jed G. Nuchtern, Shahab Asgharzadeh, Araz Marachelian, John M. Maris, Rochelle Bagatell, Julie R. Park, Meredith S. Irwin, Michael D. Hogarty, Hiroyuki Shimada

DOI: 10.1158/1078-0432.31006693

Cited by: 0

Abstract

Children’s Oncology Group Revised Neuroblastoma Risk Classification.

Fields of Study & Subjects

Neuroblastoma Research and Treatments Virus-based gene therapy research Vitamin C and Antioxidants Research

Publication details

Publication date: 6 January 2026